TITLE

Testosterone and male ageing: spinning the wheels

AUTHOR(S)
Handelsman, David J.
PUB. DATE
October 2010
SOURCE
Medical Journal of Australia;10/4/2010, Vol. 193 Issue 7, p379
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on two research studies showing the effect of testosterone treatment of aging on men. He argues that the article on the European Male Aging Study encourages more excessive use of testosterone to treat three sexual symptoms, erectile dysfunction, frequency of morning erections, and sexual desire. On the second article, he explains that the results of the study showed a poor cardiovascular safety margin for testosterone supplementation in older men.
ACCESSION #
54946508

 

Related Articles

  • Testosterone Replacement Therapy and Mortality in Older Men. Hackett, G. // Drug Safety;Feb2016, Vol. 39 Issue 2, p117 

    While US testosterone prescriptions have tripled in the last decade with lower trends in Europe, debate continues over the risks, benefits and appropriate use of testosterone replacement therapy (TRT). Several authors blame advertising and the availability of more convenient formulations, whilst...

  • SHORT CUTS. Tonks, Alison // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/24/2011, Vol. 343 Issue 7824, p612 

    The article discusses various developments related to medical research. GlaxoSmithKline's latest malaria vaccine has failed to prevent clinical disease in a recent trial in Mali. Depression in adults is associated with a higher risk of stroke. The article also highlights the findings of a report...

  • Clinical use of alprostadil topical cream in patients with erectile dysfunction: a review. Anaissie, James; Hellstrom, Wayne J. G. // Research & Reports in Urology;Aug2016, Vol. 8, p123 

    Erectile dysfunction (ED) is a common and debilitating disorder seen in over 50% of men older than 70 years. Oral phosphodiesterase type 5 (PDE5) inhibitors are the mainstay of treatment for ED, but cannot be used by a significant subset of patients due to systemic side effects and...

  • Erectile dysfunction: risk factor or manifestation of cardiovascular disease? Chien, C. V.; Schwarz, E. R. // International Journal of Impotence Research;Sep2007, Vol. 19 Issue 5, p446 

    The author reflects on the risk factor or manifestation of cardiovascular disease to erectile dysfunction. He defined penile erection as a complex physiologic process involving cooperation between neurologic, vascular, hormonal and myogenic systems. He discusses the mechanism of erectile...

  • Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Bank, A.J.; Billups, K.L.; Kaiser, D.R.; Kelly, A.S.; Wetterling, R.A.; Tsai, M.Y.; Hanson, N. // International Journal of Impotence Research;Aug2003, Vol. 15 Issue 4, p231 

    Erectile dysfunction (ED) may be an early sign or symptom of cardiovascular disease (CVD). We examined the relation of traditional and emerging risk factors for CVD to the severity of penile vascular disease in men with ED and without clinical coronary artery disease (CAD). In total, 137 men...

  • Erectile dysfunction linked to CVD risk.  // Independent Nurse;4/30/2010, p1 

    The article discusses a study conducted by Dr Giovanni Corona and colleagues that demonstrate that cardiovascular patients with low testosterone levels exhibit higher mortality rates than the ones with high testosterone levels.

  • Erectile dysfunction indicator for CVD.  // New Zealand Doctor;6/30/2010, p14 

    The article highlights the results of research which shows that erectile dysfunction (ED) often predates cardiovascular disease (CVD) and is regarded as an independent predictor of CVD similar other risk factors like hypertension and smoking.

  • Statistically Significant.  // Cortlandt Forum;Apr2006, Vol. 19 Issue 4, p12 

    The article presents statistical data related to the chances of developing cardiovascular disease among men in the U.S. Based on the Framingham Heart Study, the chance of developing cardiovascular disease by men at 95 years old without risk factors at age 50 is 5.2 percent. On the other hand,...

  • Hearing Loss and Drugs for Erectile Dysfunction.  // ASHA Leader;11/27/2007, Vol. 12 Issue 16, p5 

    The article discusses an investigation by the U.S. Food and Drug Administration (FDA) into the belief that the use of certain drugs, including Viagra, Levitra, Cialis, and Revatio, may lead to some hearing loss. The FDA has updated the labeling and adverse reactions that is provided with these...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics